PTSD can cloud your entire life. If you haven’t yet found relief, you may be eligible for PTSD investigational treatment under a clinical research study, using Brainsway’s Deep TMS. This non-invasive technology, approved by FDA for Depression, might potentially by your way out.

Take Part in a New Research Study Treatment

  • Brief sessions - 20 minutes x 3 days x 4 weeks
  • Adminsistered by experts in leading medical centers in the US & Canada
  • No medication intake, no systemic side effects
  • FDA-approved for treating depression. Approved for PTSD research in Europe.
  • No cost for eligible participants, no insurance needed

Subject's Eligibility Criteria

  • Aged 22-68
  • Suffering from Post-Traumatic Stress Disorder (PTSD)
  • No prior TMS treatment
Check Your Eligibility for the Study Treatment